LU78997A1 - Procede en vue de provoquer une tolerance immunologique - Google Patents
Procede en vue de provoquer une tolerance immunologiqueInfo
- Publication number
- LU78997A1 LU78997A1 LU78997A LU78997A LU78997A1 LU 78997 A1 LU78997 A1 LU 78997A1 LU 78997 A LU78997 A LU 78997A LU 78997 A LU78997 A LU 78997A LU 78997 A1 LU78997 A1 LU 78997A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- procedure
- immunological tolerance
- inducing immunological
- inducing
- tolerance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
- Y10S524/90—Antigen-antibody
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/764,586 US4191668A (en) | 1977-02-03 | 1977-02-03 | Induction of immunological tolerance |
Publications (1)
Publication Number | Publication Date |
---|---|
LU78997A1 true LU78997A1 (fr) | 1978-06-21 |
Family
ID=25071153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU78997A LU78997A1 (fr) | 1977-02-03 | 1978-02-03 | Procede en vue de provoquer une tolerance immunologique |
Country Status (17)
Country | Link |
---|---|
US (1) | US4191668A (fr) |
JP (1) | JPS53121943A (fr) |
AU (1) | AU515181B2 (fr) |
BE (1) | BE863656A (fr) |
CA (1) | CA1118347A (fr) |
CH (1) | CH644521A5 (fr) |
DE (1) | DE2804457C2 (fr) |
DK (1) | DK155174C (fr) |
FI (1) | FI780312A (fr) |
FR (1) | FR2379287A1 (fr) |
GB (1) | GB1599454A (fr) |
LU (1) | LU78997A1 (fr) |
MX (1) | MX6266E (fr) |
NL (1) | NL7801220A (fr) |
NO (1) | NO153419C (fr) |
SE (1) | SE464616B (fr) |
ZA (1) | ZA78613B (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4220565A (en) * | 1979-01-18 | 1980-09-02 | Scripps Clinic & Research Foundation | Immunochemical conjugates: method and composition |
US4276206A (en) * | 1979-01-18 | 1981-06-30 | Scripps Clinic & Research Foundation | Immunochemical conjugates: method and composition |
US4253995A (en) * | 1980-02-11 | 1981-03-03 | Scripps Clinic And Research Foundation | Immunochemical conjugates: method and composition |
US4253996A (en) * | 1980-02-13 | 1981-03-03 | Scripps Clinic And Research Foundation | Immunochemical conjugates: method and composition |
DE3114362C2 (de) * | 1980-04-11 | 1983-08-18 | Toshiyuki Prof. Nara Hamaoka | Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung |
EP0077158A1 (fr) * | 1981-10-09 | 1983-04-20 | Beecham Group Plc | Allergènes modifiés |
US5126131A (en) * | 1983-01-24 | 1992-06-30 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates. |
US5370871A (en) * | 1983-01-24 | 1994-12-06 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US6022544A (en) | 1983-01-24 | 2000-02-08 | The John Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US4950469A (en) * | 1986-05-30 | 1990-08-21 | La Jolla Pharmaceutical Company | D-GL conjugate therapy |
US5017648A (en) * | 1986-05-30 | 1991-05-21 | La Jolla Pharmaceutical Company | D-GL conjugate therapy |
CA1309558C (fr) * | 1986-05-30 | 1992-10-27 | Quidel | Conjugue d-gl, agent therapeutique |
US4950713A (en) * | 1986-05-30 | 1990-08-21 | La Jolla Pharmaceutical Company | Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals |
US5268454A (en) * | 1991-02-08 | 1993-12-07 | La Jolla Pharmaceutical Company | Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier |
US5552391A (en) * | 1990-01-16 | 1996-09-03 | La Jolla Pharmaceutical Company | Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
US5162515A (en) * | 1990-01-16 | 1992-11-10 | La Jolla Pharmaceutical Company | Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
US5391785A (en) * | 1990-01-16 | 1995-02-21 | La Jolla Pharmaceutial Company | Intermediates for providing functional groups on the 5' end of oligonucleotides |
CA2073846C (fr) * | 1991-07-15 | 2007-09-18 | David S. Jones | Intermediaires phosphores modifies servant de groupements fonctionnels a l'extremite 5' d'oligonucleotides |
KR100361933B1 (ko) * | 1993-09-08 | 2003-02-14 | 라 졸라 파마슈티칼 컴파니 | 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트 |
US8071737B2 (en) | 1995-05-04 | 2011-12-06 | Glead Sciences, Inc. | Nucleic acid ligand complexes |
US6410775B1 (en) * | 1995-06-07 | 2002-06-25 | La Jolla Pharmaceutical Company | APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
US5874409A (en) | 1995-06-07 | 1999-02-23 | La Jolla Pharmaceutical Company | APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
US6858210B1 (en) | 1998-06-09 | 2005-02-22 | La Jolla Pharmaceutical Co. | Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same |
US6399578B1 (en) | 1998-12-09 | 2002-06-04 | La Jolla Pharmaceutical Company | Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same |
US6458953B1 (en) | 1998-12-09 | 2002-10-01 | La Jolla Pharmaceutical Company | Valency platform molecules comprising carbamate linkages |
US20030039659A1 (en) * | 1999-09-24 | 2003-02-27 | Mccormick Alison A. | Self antigen vaccines for treating B cell lymphomas and other cancers |
US7084256B2 (en) * | 1999-09-24 | 2006-08-01 | Large Scale Biology Corporation | Self antigen vaccines for treating B cell lymphomas and other cancers |
AU2001268228A1 (en) | 2000-06-08 | 2001-12-17 | La Jolla Pharmaceutical Company | Multivalent platform molecules comprising high molecular weight polyethylene oxide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1282163A (en) * | 1969-08-06 | 1972-07-19 | Beecham Group Ltd | Modified allergens and a process for their preparation |
US3825525A (en) * | 1969-08-06 | 1974-07-23 | Beecham Group Ltd | Allergens reacted with carbodiimides |
-
1977
- 1977-02-03 US US05/764,586 patent/US4191668A/en not_active Expired - Lifetime
-
1978
- 1978-01-31 CA CA000295952A patent/CA1118347A/fr not_active Expired
- 1978-01-31 FI FI780312A patent/FI780312A/fi not_active Application Discontinuation
- 1978-02-01 ZA ZA00780613A patent/ZA78613B/xx unknown
- 1978-02-02 DE DE2804457A patent/DE2804457C2/de not_active Expired
- 1978-02-02 SE SE7801268A patent/SE464616B/xx unknown
- 1978-02-02 GB GB4310/78A patent/GB1599454A/en not_active Expired
- 1978-02-02 JP JP1105378A patent/JPS53121943A/ja active Granted
- 1978-02-02 DK DK049178A patent/DK155174C/da not_active IP Right Cessation
- 1978-02-02 NL NL7801220A patent/NL7801220A/xx not_active Application Discontinuation
- 1978-02-02 NO NO780366A patent/NO153419C/no unknown
- 1978-02-03 MX MX786822U patent/MX6266E/es unknown
- 1978-02-03 CH CH124078A patent/CH644521A5/de not_active IP Right Cessation
- 1978-02-03 BE BE184908A patent/BE863656A/fr not_active IP Right Cessation
- 1978-02-03 LU LU78997A patent/LU78997A1/fr unknown
- 1978-02-03 FR FR7803063A patent/FR2379287A1/fr active Granted
- 1978-02-05 AU AU32933/78A patent/AU515181B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK49178A (da) | 1978-08-04 |
DK155174B (da) | 1989-02-27 |
DK155174C (da) | 1989-07-10 |
AU3293378A (en) | 1979-08-09 |
GB1599454A (en) | 1981-10-07 |
BE863656A (fr) | 1978-05-29 |
DE2804457A1 (de) | 1978-08-10 |
SE464616B (sv) | 1991-05-27 |
MX6266E (es) | 1985-02-27 |
CA1118347A (fr) | 1982-02-16 |
SE7801268L (sv) | 1978-08-04 |
FR2379287B1 (fr) | 1980-08-29 |
FR2379287A1 (fr) | 1978-09-01 |
ZA78613B (en) | 1978-12-27 |
DE2804457C2 (de) | 1984-04-12 |
JPH0428689B2 (fr) | 1992-05-15 |
NO153419B (no) | 1985-12-09 |
JPS53121943A (en) | 1978-10-24 |
NL7801220A (nl) | 1978-08-07 |
FI780312A (fi) | 1978-08-04 |
CH644521A5 (de) | 1984-08-15 |
US4191668A (en) | 1980-03-04 |
AU515181B2 (en) | 1981-03-19 |
NO153419C (no) | 1986-03-19 |
NO780366L (no) | 1978-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU78997A1 (fr) | Procede en vue de provoquer une tolerance immunologique | |
SE7803475L (sv) | Hallare for pasar | |
SE7803476L (sv) | Hallare for pasar | |
BE864856A (fr) | Procede de determination immunologique | |
BE873136A (fr) | Procede de preparation de la vincadifformine | |
FI780645A (fi) | Foer industriellt bruk avsedd flaekt med under drift varierbar bladstigning | |
SE7805258L (sv) | Stralkastare | |
SE7712754L (sv) | Bervegg for rorslingor | |
AT364318B (de) | Bauelementsystem | |
BE857244A (fr) | Procede de preparation de 3-chlorocephalosporines | |
BE866490A (fr) | Procede de dosage | |
BE866602A (fr) | Arrangement de came | |
SE7812411L (sv) | Instas for eldstad | |
FR2345454A1 (fr) | Procede de preparation de 3-halomethylcephemes | |
BE860267R (fr) | Procede de preparation de para-alkylphenols | |
ES244818Y (es) | Dispositivo de fijacion auto-retenido | |
SE7807813L (sv) | Platta for plattkondensor | |
BR7803504A (pt) | Dispositivo para processamento de generos alimenticios | |
FI780216A (fi) | Anordning foer faergtelevisionsmottagare | |
FR2342968A1 (fr) | Procede de preparation de 3-desoxyanthocyanidines | |
RO71278A (fr) | Procede pour le traitement des residus de distillation de hydroformylation du propene | |
BE868117A (fr) | Procede de dimerisation | |
BE870104A (fr) | Procede de preparation de 2-chlorosulfinyl-azetidin-4-ones | |
BE866904A (fr) | Procede de preparation de 3-bromophtalide | |
BE850632R (fr) | Procede de preparation de para-alkylphenols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transfer of rights |
Free format text: 860903 SCRIPPS CLINIC & RESEARCH FOUNDATION LA JOLLA |